Concepedia

Gayle Grigson

GG

Statistics

Publications

8

Citations

746

H-Index

8

Active since

2006

Affiliations

University of North Carolina at Chapel Hill(Current)

Duke Medical Center

Duke University Hospital

UNC Lineberger Comprehensive Cancer Center

National Cancer Institute

Gayle Grigson is an author at University of North Carolina at Chapel Hill specializing in radiation oncology, urology, and medicine.

Top concepts

Publications per year

2006–2011

8

Publications

8

Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

C. Lance Cowey, Chirag Amin, Raj S. Pruthi et al. · Journal of Clinical Oncology · 2010 · 197 citations · Full text

Phase II Trial of Sorafenib Plus Interferon Alfa-2b As First- or Second-Line Therapy in Patients With Metastatic Renal Cell Cancer

Jared Gollob, W. Kimryn Rathmell, Tina M. Richmond et al. · Journal of Clinical Oncology · 2007 · 181 citations · Full text

A phase II trial of neoadjuvant erlotinib in patients with muscle‐invasive bladder cancer undergoing radical cystectomy: clinical and pathological results

Raj S. Pruthi, Matthew E. Nielsen, Samuel A. Heathcote et al. · British Journal of Urology · 2010 · 113 citations

Phase II Trial of Celecoxib in Prostate-Specific Antigen Recurrent Prostate Cancer after Definitive Radiation Therapy or Radical Prostatectomy

Raj S. Pruthi, J. Eric Derksen, Dominic T. Moore et al. · Clinical Cancer Research · 2006 · 97 citations

A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer

Young E. Whang, Andrew J. Armstrong, W. Kimryn Rathmell et al. · Urologic Oncology Seminars and Original Investigations · 2011 · 85 citations

, , +7

1–5 of 8